ISSN 1308-7649 | E-ISSN 2148-3817
RELATED ARTICLES
Review
European Position Statement on Diagnosis, and Treatment of Meniere’s Disease*
(J Int Adv Otol 2018; 14: 317-321)
DOI: 10.5152/iao.2018.140818
Original Article
Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2018.4871.
The Role of High Dose Intratympanic Dexamethasone as Salvage Therapy for Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol 2017; 13: 318-321)
DOI: 10.5152/iao.2017.3896
Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2018.4871.
A Comparison of Two Vasoactive/Vasodilative Agents in Combination with Corticosteroid for Treatment of Sudden Sensorineural Hearing Loss
(J Int Adv Otol 2014; 10: 240-245)
DOI: 10.5152/iao.2014.102
Cochlear and Vestibular Effects of Combined Intratympanic Gentamicin and Dexamethasone
(J Int Adv Otol 2017; 13: 47-52)
DOI: 10.5152/iao.2016.2181
Comparison of Long-Term Outcome of Intratympanic Dexamethasone Therapy between Acute Noise-Induced Tinnitus and Acute Idiopathic Tinnitus
(J Int Adv Otol 2017; 13: 53-60)
DOI: 10.5152/iao.2016.2632
Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere’s Disease Patients
(J Int Adv Otol 2016; 12: 92-97)
DOI: 10.5152/iao.2016.2177
Efficacy of Cortexin and Methylprednisolone on Traumatic Facial Nerve Paralysis
(J Int Adv Otol 2016; 12: 303-309)
DOI: 10.5152/iao.2016.1166
A Pilot Study Using Intratympanic Methylprednisolone for Treatment of Persistent Posterior Canal Benign Paroxysmal Positional Vertigo
(J Int Adv Otol 2016; 12: 321-325)
DOI: 10.5152/iao.2016.3014
Key Words
Authors
All
Author's Corner
Reviewer's Corner
Survey
AVES | Copyright © 2018 The European Academy of Otology and Neurotology | Latest Update: 16.08.2018